The burden of autoimmunity in myelodysplastic syndromes
- 27 April 2017
- journal article
- review article
- Published by Wiley in Hematological Oncology
- Vol. 36 (1), 15-23
- https://doi.org/10.1002/hon.2423
Abstract
The clinical history of patients with myelodysplastic syndromes (MDS) is characterised by bone marrow insufficiency as well as by the possible evolution into acute leukaemia. However a number of reports highlight the frequent occurrence of autoimmune manifestations involving different sites and organs. The present review will first describe the clinical pictures most often observed in MDS patients. The actual burden of autoimmunity will be then addressed by focusing on the few available registry studies. Finally, the potential collateral impact of specific treatments for MDS on the evolution of autoimmune disorders will be considered.This publication has 109 references indexed in Scilit:
- Are T‐cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?European Journal of Haematology, 2012
- Large-vessel thrombosis in intestinal Behçet’s disease complicated with myelodysplastic syndrome and trisomy 8World Journal of Gastroenterology, 2012
- Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic SyndromeCase Reports in Hematology, 2011
- Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic SyndromesJournal of Clinical Oncology, 2011
- Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cellsLeukemia Research, 2011
- The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three casesBritish Journal of Haematology, 2011
- Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4+ subset and oligoclonal in the CD8+ subsetExperimental Hematology, 2009
- Risks of myeloid malignancies in patients with autoimmune conditionsBritish Journal of Cancer, 2009
- Is thyroid autoimmunity a risk factor for developing primary myelodysplastic syndrome?Cancer Causes & Control, 2007
- Myelodysplastic and Myeloproliferative Syndromes Associated with Giant Cell Arteritis and Polymyalgia Rheumatica: A Coincidental Coexistence or a Causal Relationship?Clinical Rheumatology, 2002